A carregar...
New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
Although sarcomas account for a small portion of solid malignancies, currently, there are few treatment options for sarcomas, particularly for advanced disease. The mammalian target of rapamycin (mTOR), a serine-threonine protein kinase in the phosphatidylinositol 3-kinase/serine/threonine protein k...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412949/ https://ncbi.nlm.nih.gov/pubmed/21837674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26361 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|